Fiera Capital (Canada)’s iShares Biotechnology ETF IBB Stock Holding History

Fiera Capital (Canada)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,118	Closed	-$558K	–	664
2020 Q3	$558K	Hold	4,118	–	–	﹤0.01%	460
2020 Q2	$563K	Buy	4,118 +200	+5%	+$25.5K	﹤0.01%	463
2020 Q1	$422K	Buy	3,918 +2,003	+105%	+$231K	﹤0.01%	503
2019 Q4	$231K	Buy	+1,915	New	+$214K	﹤0.01%	621
2019 Q3	–	Sell	-1,915	Closed	-$209K	–	665
2019 Q2	$209K	Hold	1,915	–	–	﹤0.01%	610
2019 Q1	$214K	Buy	+1,915	New	+$210K	﹤0.01%	628
2018 Q4	–	Sell	-1,915	Closed	-$234K	–	692
2018 Q3	$234K	Sell	1,915 -765	-29%	-$90.1K	﹤0.01%	648
2018 Q2	$294K	Sell	2,680 -431	-14%	-$46.1K	﹤0.01%	608
2018 Q1	$332K	Buy	+3,111	New	+$345K	﹤0.01%	565
2016 Q4	–	Sell	-7,920	Closed	-$764K	–	784
2016 Q3	$764K	Hold	7,920	–	–	﹤0.01%	556
2016 Q2	$679K	Sell	7,920 -105	-1%	-$9.42K	﹤0.01%	616
2016 Q1	$698K	Hold	8,025	–	–	0.01%	444
2015 Q4	$905K	Hold	8,025	–	–	0.01%	437
2015 Q3	$811K	Buy	+8,025	New	+$963K	0.01%	392

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Fiera Capital (Canada)'s IBB Position: Q4 2020 in Review

Fiera Capital (Canada) sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 4,118 shares — an estimated $558K sold.

Fiera Capital (Canada) first reported a position in IBB in Q3 2015 and held it in 14 quarters. The position peaked at $905K in Q4 2015. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

Fiera Capital (Canada) reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
Fiera Capital (Canada) sold 4,118 iShares Biotechnology ETF shares in Q4 2020, an estimated $558K.
Fiera Capital (Canada) first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 14 quarters.
Fiera Capital (Canada)'s iShares Biotechnology ETF position peaked at $905K in Q4 2015.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2020, filed 9 Feb 2021.